...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Share transfer RBC
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Koo

I agree with you 100%

I have been pushing for Zenith to put forth a proper market value for common shares for years and have spoken to various board members with no success.

If Zenith meets or exceeds my expectations, having shares sheltered is my number one goal.

 

GLTA dyodd

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply